Anthea Di Rita trained as cellular and molecular biologist at the laboratory of Prof. Francesco Cecconi at the University of Rome Tor Vergata (Italy), where she obtained her Master degree in Cellular and Molecular Biology in 2014 and then a PhD in Cellular and Molecular Biology in 2017. Her PhD thesis dealt with the role of AMBRA1 protein in a selective form of autophagy for mitochondria clearance, known as mitophagy, in physiologic and pathologic conditions. She worked as post-doctoral fellow in the laboratory of Dr. Flavie Strappazzon at the IRCCS Santa Lucia Foundation (Rome, Italy), where she obtained the certificate FESALA licenses for performing and directing experiments involving animals. During her first Post-Doc, she consolidated her expertise in mitochondrial biology expanding her competences in mitochondria-related micro-RNA (miRNA) regulation and autoimmunity diseases, such as Multiple Sclerosis. She has recently joined the group led by Dr. Anna Kabanova at Fondazione Toscana Life Sciences (TLS) in Siena. She works on the AIRC granted project focused on the inhibitory gene expression programs in the Chronic Lymphocytic Leukaemia (CLL) and their therapeutic potential.
Cristina Tinti email@example.com
Principal Investigator of the Tumour Immunology Unit: